8-K
filed April 13, 2023, 7:59 PM ET
ticker ADIL
CIK 0001513525
other material
confidence high
sentiment neutral
materiality 0.60
Adial Pharmaceuticals stockholders approve reverse stock split range of 1:2 to 1:50
ADIAL PHARMACEUTICALS, INC.
- Approved amendment to Certificate of Incorporation to effect reverse stock split at Board's discretion within 1:2 to 1:50 range.
- Votes: 16,585,304 for, 2,050,482 against, 28,565 abstentions; broker non-votes not applicable.
- Board has one year from April 12, 2023 to implement or authority terminates.
- Adjournment proposal also approved but not needed as Proposal 1 passed.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ADIAL PHARMACEUTICALS, INC. shareholders approved Approval of an adjournment of the Special Meeting to a later date, if necessary, to permit further solicitation and vote of proxies at the 2023-04-12 meeting.
- Outcome
- passed
- Meeting
- 2023-04-12
Exact text from the filing
The stockholders approved Proposal 2 based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 17,465,868 1,135,263 63,222 -
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ADIAL PHARMACEUTICALS, INC. shareholders approved Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio in the range of 1-for-2 to 1-for-50 at the 2023-04-12 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-04-12
Exact text from the filing
The stockholders approved Proposal 1 to amend the Certificate of Incorporation based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 16,585,304 2,050,482 28,565 -
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.